Bridgeway Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Bridgeway Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$382K	Sell	41,992 -10,000	-19%	-$126K	0.01%	877
2025 Q4	$711K	Sell	51,992 -15,000	-22%	-$278K	0.01%	759
2025 Q3	$1.46M	Hold	66,992	–	–	0.03%	633
2025 Q2	$800K	Hold	66,992	–	–	0.02%	691
2025 Q1	$797K	Hold	66,992	–	–	0.02%	676
2024 Q4	$1.03M	Hold	66,992	–	–	0.02%	664
2024 Q3	$751K	Hold	66,992	–	–	0.02%	751
2024 Q2	$361K	Hold	66,992	–	–	0.01%	928
2024 Q1	$456K	Hold	66,992	–	–	0.01%	950
2023 Q4	$455K	Hold	66,992	–	–	0.01%	962
2023 Q3	$336K	Buy	+66,992	New	+$399K	0.01%	989
2020 Q1	–	Sell	-10,500	Closed	-$50K	–	1292
2019 Q4	$50K	Buy	+10,500	New	+$43.4K	﹤0.01%	1277

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bridgeway Capital Management's CLPT Position: Q1 2026 in Review

Bridgeway Capital Management reduced its ClearPoint Neuro (CLPT) stake by 19% in Q1 2026, selling an estimated $126K and leaving 41,992 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #877.

Bridgeway Capital Management first reported a position in CLPT in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.46M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

Bridgeway Capital Management held 41,992 shares of ClearPoint Neuro worth $382K as of Q1 2026.
Bridgeway Capital Management sold 10,000 ClearPoint Neuro shares in Q1 2026, an estimated $126K.
ClearPoint Neuro made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #877 holding.
Bridgeway Capital Management first reported a position in ClearPoint Neuro in Q4 2019 and has held it in 12 quarters since.
Bridgeway Capital Management's ClearPoint Neuro position peaked at $1.46M in Q3 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.